People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Precision Therapeutics Inc | — | Other Health Care | Series B | $48.0M | $310.2M | 2010 |
Mike R. Gabrin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mike R. Gabrin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard S. Kollender | 1 | 7 |
| Sean McDonald | 1 | 6 |
| Joel P. Adams | 1 | 4 |
| Stanley N. Lapidus | 1 | 4 |
| Kevin P. Johnson | 1 | 3 |
| Todd C. Davis | 1 | 3 |
| Clarke B. Futch | 1 | 2 |
| David P. Hirsch | 1 | 1 |
| David R. Heilman | 1 | 1 |
| Mike C. Gabrin | 1 | 1 |
| Holly H. Gallion, M.D. | 1 | 1 |
| Sharon H. Kim | 1 | 1 |
| Jeff N. Crisan | 1 | 1 |
| Matthew T. Reber | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.